MEDA

MEDA
Names
	IUPAC name 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number	23693-25-6 ;
3D model (Jmol)	Interactive image;
ChemSpider	24034 ;
KEGG	D03376 ;
PubChem CID	25798;
	InChI InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: NRVFDGZJTPCULU-UHFFFAOYSA-N ; InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: HEYPARQBPGSFKW-UHFFFAOYSA-N ;
	SMILES NC(CC1=CC2=C(OCCO2)C(OC)=C1)C ;
Properties
Chemical formula	C12H17NO3
Molar mass	223.268 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	verify (what is ?)
	Infobox references

MEDA, or 3-methoxy-4,5-ethylenedi oxy amphetamine, is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200 mg, and the duration unknown. MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

External links[edit]

This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it.